BTNX Inc. is a biotechnology company and a world leader in rapid, point-of-care diagnostics. We specialize in innovation, research, development and manufacturing of advanced in-vitro diagnostic (IVD) tests for laboratories, clinics, hospitals and physicians’ offices. BTNX Inc. also develops information technology systems to manage point-of-care diagnostic test results using HL7/POCT1-A2 compliant software solutions.
Fentanyl Forensic Test Strips
Excerpt - The Rapid ResponseTM Fentanyl (FYL) Forensic Test Strip is a lateral flow chromatographic immunoassay for the qualitative detection of Fentanyl/Norfentanyl in urine and liquid and powder substances. It is specific for Fentanyl screening with no significant cross reactivity to other opiates, such as Morphine and Heroin.More Information
Excerpt - The COVID-19 IgG/IgM Rapid Test Device is the first FDA Emergency Use Authorized Rapid, Point-of-Care, CLIA Waived COVID-19 antibody test. This test is used for the detection of anti-SARS-CoV-2 IgM and IgG antibodies in human whole blood, serum, or plasma samples. This test has been authorized for use with fingerstick blood, intended for identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection to the disease. In just 15 minutes, you are able to provide patients & clients actionable information at the Point of Care!More Information